European Open: Equities and oil rise on China reopening, US CPI in focus
Sentiment was given another boost ahead of today’s US CPI report with China continuing to scale back restrictions and suggesting international travel could be on the horizon.
Articles tagged with "covid-and-trading"
Stay in step with market opportunities and get insights, actionable trade ideas and dedicated support.
IAG Q1 preview: Where next for the IAG share price?
IAG faces a major challenge as it strives to return to profit in 2022 as a myriad of headwinds plague the airline industry.
AstraZeneca Q1 preview: Where next for AstraZeneca stock?
AstraZeneca’s results will benefit from the acquisition of Alexion, but questions remain over its Covid-19 drugs and the outlook in China.
Index in focus: A50 bears in control as COVID spreads in China
Why the COVID outbreak across the country may well get worse before it gets better...
Copper selling intensifies on China
More than 2 years into the pandemic and Covid is still roiling financial markets.
Chinese yuan, stocks and commodities slump
Just when you thought the c-word was no more a thing for the markets…
BioNTech Q4 preview: Where next for BioNTech stock?
BioNTech has become a world-renowned name thanks to its Covid-19 vaccine, but how will it perform in 2022 as the pandemic continues to ease?
Asian Open: UK logs first known Omicron death
The United Kingdom has recorded the first known Omicron-related death, as the World Health Organisation warns that variant could pose as a global risk.
Asian Open: Omicron detected in around one third of US states
Sentiment remained weak on Friday with a soft employment print not helping, although futures markets are lower with reports of Omicron spreading across the US.
Asian Open: Omicron spreads to its 29th country, including the US
The Omicron continues to make waves as it now accounts for around three quarters of cases in South Africa, with the US now reporting its first case.
Risk-off returns as Moderna CEO makes glum prediction
An article in the Financial Times triggered a fresh round of selling before the European open, as Moderna’s CEO predicts vaccines will be less effective.
easyJet FY preview: Where next for the easyJet share price?
A new COVID variant threatens to cast the airline and travel industry back into turmoil as new travel restrictions are introduced. We have a look at what it could mean for easyJet ahead of its annual earnings.
New COVID strain shakes the market, is it downhill from here?
The discovery of a new COVID strain which could be vaccine resistant has rattled traders. Here we look at which markets have been most affected and what to watch for going forwards.
StoneX Europe Ltd may make third party material available on this website which may contain information included but not limited to the conditions of financial markets. The material is for information purposes only and does not contain, and should not be construed as containing, investment advice and/or investment recommendation and/or an investment research and/or an offer of or solicitation for any transactions in financial instruments; any decision to enter into a specific transaction shall be made by the client following an assessment by him/her of their situation.
StoneX Europe Ltd makes no representation or warranty and assumes no liability as to the accuracy or completeness of the information provided, nor any loss arising from any investment based on a recommendation, forecast or other information supplied. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. We are not under any obligation to update any such material. Any opinion made may be personal to the author and may not reflect the opinion of StoneX Europe Ltd.